Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring
Randy M. Stalter(University of Washington), Felix Mhlanga, Sharon L. Hillier(Magee-Womens Research Institute), Gonasagrie Nair, Zakir Gaffoor(South African Medical Research Council), Nitesha Jeenarain, Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Samantha Siva, Craig W. Hendrix(Unknown), Bonus Makanani(University of Malawi), Jared M. Baeten(University of Washington), Elizabeth Brown(University of Washington), Thesla Palanee‐Phillips(University of the Witwatersrand), Vaneshree Govender(South African Medical Research Council), Ariane van der Straten(University of California, San Francisco), Flavia Matovu Kiweewa(MUJHU Research Collaboration), Katie Schwartz(University of Wyoming), Mark A. Marzinke(Family Health International 360), Arendevi Pather, Elizabeth R. Brown(Fred Hutch Cancer Center), Tracy Qi Dong(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Logashvari Naidoo(South African Medical Research Council), Nyaradzo Mgodi(University of Zimbabwe), Lydia Soto‐Torres(National Institutes of Health), Francis Martinson
Cited by 2
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
|New England Journal of Medicine|2000|679